| HFLGX | VMVAX | HFLGX / VMVAX | |
| Total Expense Ratio | 1.27 | 0.07 | 1,814% |
| Annual Report Gross Expense Ratio | 1.27 | 0.07 | 1,814% |
| Fund Existence | 17 years | 14 years | - |
| Gain YTD | 6.177 | 8.872 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 135M | 31.8B | 0% |
| Annual Yield % from dividends | 0.88 | 2.20 | 40% |
| Returns for 1 year | -3.43 | 2.82 | -122% |
| Returns for 3 years | 5.36 | 26.82 | 20% |
| Returns for 5 years | 10.43 | 56.57 | 18% |
| Returns for 10 years | 1.08 | 108.57 | 1% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FITIX | 23.00 | N/A | N/A |
| Fidelity Advisor Mid Cap II M | |||
| RYMVX | 75.91 | -0.95 | -1.24% |
| Rydex S&P MidCap 400 Pure Value A | |||
| DLQIX | 16.90 | -0.29 | -1.69% |
| BNY Mellon Large Cap Equity I | |||
| HRAUX | 81.84 | -1.85 | -2.21% |
| Carillon Eagle Mid Cap Growth R6 | |||
| CTSIX | 44.77 | -2.26 | -4.81% |
| Calamos Timpani Small Cap Growth I | |||